ATLATL Scientific and Miltenyi Biotec: A Five-Year Partnership Driving Biotech Innovation in Singapore and Beyond
30 Abril 2024 - 10:55AM
Business Wire
ATLATL Scientific and Miltenyi Biotec are celebrating a landmark
five-year partnership, marking a journey of collaboration and
innovation in the biotech sector. With a strong foundation laid
over the years, this partnership has flourished into a dynamic
alliance poised to drive significant advancements in
biotechnology.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240430526379/en/
ATLATL Scientific and Miltenyi Biotec are
celebrating a landmark five-year partnership (Photo: Business
Wire)
Since the inception of their partnership five years ago, ATLATL
Scientific and Miltenyi Biotec have worked closely together to
leverage their respective expertise and resources. The
collaboration in Singapore builds upon the foundation set by their
successful ventures, including the CliniMACS Cell Factory® and the
MACS® Innovation & Technology Center, MITC Beijing. As ATLATL
Scientific expands its presence into Singapore, Miltenyi Biotec
emerges as a key partner, contributing multiple platforms such as
CliniMACS Prodigy® and CliniMACS Plus to ATLATL's incubator at
Helios Biopolis. This strategic collaboration underscores Miltenyi
Biotec's commitment to supporting innovative startups and driving
technological advancements in the biotech ecosystem.
The partnership between ATLATL Scientific and Miltenyi Biotec
was further solidified at AsiaBio 2024, where they co-sponsored the
event as booth partners. At the event, both companies signed a
Memorandum of Understanding (MOU) to signify their continued
partnership and strengthen their ties as they expand their presence
in Singapore. This collaboration sets the stage for future joint
initiatives aimed at fostering innovation and driving growth in the
biotech sector.
Looking ahead, ATLATL Scientific and Miltenyi Biotec are poised
to embark on co-research and co-development projects in Singapore.
These initiatives will not only bolster both companies' presence in
the local biotech ecosystem but also cement Miltenyi Biotec's
position as a prominent maker of cutting-edge equipment for Cell
and Gene Therapy. By combining their strengths and resources,
ATLATL Scientific and Miltenyi Biotec aim to drive transformative
impact in the biotech industry, both locally and globally.
As they look beyond AsiaBio 2024, ATLATL Scientific and Miltenyi
Biotec are committed to further collaborations in different global
sites, including China, US, and Europe area. These initiatives
underscore their shared vision of driving innovation and advancing
biotechnology on a global scale.
The partnership between ATLATL Scientific and Miltenyi Biotec
represents a testament to the power of collaboration in driving
scientific innovation. As they celebrate five years of partnership,
both companies are poised to build upon their achievements and
drive even greater impact in the years to come.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240430526379/en/
info@atlatl.center